Cite
HARVARD Citation
Oostvogels, R. et al. (2018). Efficacy of retreatment with immunomodulatory drugs and proteasome inhibitors following daratumumab monotherapy in relapsed and refractory multiple myeloma patients. British journal of haematology. pp. 60-67. [Online].